Variations in TFAM expression tended to be different between the two groups (p = 0.083; Figure 5D) with enhanced expression in healthy myotubes (+19.0%) and reduced expression in COPD myotubes (−9.8%). This evidence concerns the gene TFAM and chronic obstructive pulmonary disease.